The GABAergic Inhibitory System in Drug Resistant Epilepsy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to investigate the effect of lovastatin on neurotransmission and neuroinflammation in patients with temporal lobe onset drug resistant epilepsy. Structure: (1) Visit 1: 3 consecutive days of physiologically probing drug/placebo intake, (2) Visit 2: Outcome measures and additional evaluations in the day after the last drug/placebo intake, (3) Washout period of 4 weeks, (4) 3 consecutive days of drug/placebo intake, (5) Visit 3: Outcome measures and additional evaluations in the day after the last placebo/drug intake.
Epistemonikos ID: 66b6e0c8350612e1ec94253a145a34b17bc721b1
First added on: Feb 01, 2025